Alex Evans, PharmD, MBA

July 15, 2021

What does the latest research say about the association between mental health and cardiovascular disease? Scroll through our quick slideshow for an overview.

July 08, 2021

The SGLT-2 inhibitor class, originally approved as antihyperglycemic agents for T2D, has proven "pluripotent," adding indications for related conditions. Test your knowledge of a few basic facts.

May 06, 2021

Patients infected with COVID-19 have overwhelmed hospitals and their personnel. The consequences of depleted resources, severe stress, and inexperience hold essential lessons.

March 24, 2021

Dilution errors and product mix-ups were just a few early errors reported during the vaccine rollout. A PharmD shares his experience and provides guidance on how to avoid them in the future.

February 04, 2021

Acupuncture, massage, meditation—what does the latest research say about these and other popular alternative therapies for pain management?

January 13, 2021

SAMPLE: What substance was legalized this year in at least 1 US state? Psilocybin? Cocaine? Methamphetamine? Plus 6 more questions on top 2020 headlines.

October 27, 2020

Weight loss is essential to arrest the cardiovascular disease and metabolic dysfunction linked to obesity. What do you know about the drugs now available that may help?

October 23, 2020

Cardiovascular medications are widely-prescribed in the US. Alex Evans, PharmD, MBA, drafted questions on the top 5 dangerous interactions he sees regularly in practice.